AU2794199A - Thyroid hormone replacement using sustained release triiodothyronine - Google Patents

Thyroid hormone replacement using sustained release triiodothyronine

Info

Publication number
AU2794199A
AU2794199A AU27941/99A AU2794199A AU2794199A AU 2794199 A AU2794199 A AU 2794199A AU 27941/99 A AU27941/99 A AU 27941/99A AU 2794199 A AU2794199 A AU 2794199A AU 2794199 A AU2794199 A AU 2794199A
Authority
AU
Australia
Prior art keywords
triiodothyronine
sustained release
thyroid hormone
hormone replacement
replacement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27941/99A
Other languages
English (en)
Inventor
Robertas Bunevicius
Gintautas Kazanavicius
Arthur J. Prange Jr.
Rimas Zalinkevicius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARTHUR J PRANGE JR
Original Assignee
ARTHUR J PRANGE JR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARTHUR J PRANGE JR filed Critical ARTHUR J PRANGE JR
Publication of AU2794199A publication Critical patent/AU2794199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU27941/99A 1998-02-26 1999-02-26 Thyroid hormone replacement using sustained release triiodothyronine Abandoned AU2794199A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7609698P 1998-02-26 1998-02-26
US60076096 1998-02-26
US11732999P 1999-01-22 1999-01-22
US60117329 1999-01-22
PCT/US1999/004311 WO1999043307A1 (fr) 1998-02-26 1999-02-26 Remplacements d'hormones thyroidiennes au moyen de triiodothyronine a liberation lente

Publications (1)

Publication Number Publication Date
AU2794199A true AU2794199A (en) 1999-09-15

Family

ID=26757654

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27941/99A Abandoned AU2794199A (en) 1998-02-26 1999-02-26 Thyroid hormone replacement using sustained release triiodothyronine

Country Status (2)

Country Link
AU (1) AU2794199A (fr)
WO (1) WO1999043307A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608402D0 (en) * 2006-04-28 2006-06-07 Diurnal Ltd Thyroid treatment
CN103169984B (zh) 2006-07-25 2016-08-03 利普生技术有限公司 N末端聚唾液酸化
WO2008129303A2 (fr) * 2007-04-23 2008-10-30 Diurnal Limited Libération entretenue
US9968574B2 (en) * 2009-05-15 2018-05-15 The University Of Kentucky Research Foundation Treatment of MCI and Alzheimer's disease
US20100292281A1 (en) * 2009-05-15 2010-11-18 The University Of Kentucky Research Foundation Treatment of mci and alzheimer's disease
US10188739B2 (en) 2014-02-27 2019-01-29 Xenetic Biosciences, Inc. Compositions and methods for administering insulin or insulin-like protein to the brain
US10695309B2 (en) 2017-03-31 2020-06-30 Western New England University Sustained-release liothyronine formulations, method of preparation and method of use thereof
CN114786482A (zh) * 2019-11-10 2022-07-22 普鲁-阿尔医疗技术公司 新型制剂和方法
US20210196661A1 (en) * 2019-12-30 2021-07-01 Joseph Michael Abramowitz Method for amelioration of insulin resistance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3621096A (en) * 1969-04-03 1971-11-16 Univ North Carolina Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone
US3689669A (en) * 1970-10-09 1972-09-05 Univ Of North Carolina The Antidepressant method and composition
NO924985L (no) * 1991-12-30 1993-07-01 Akzo Nv Thyroaktiv blanding med vedvarende frigjoering

Also Published As

Publication number Publication date
WO1999043307A1 (fr) 1999-09-02

Similar Documents

Publication Publication Date Title
GB2338766B (en) Release bearing
GB2336921B (en) Intra-disk backup
AU2546399A (en) Preparations with controlled release
AUPP230698A0 (en) Back support
AUPP252298A0 (en) Document management software
GB2310860B (en) Stable release agents
AU3438099A (en) Error-recovery mechanism using a temporary forwarder in a wireless-atm network
AU6107698A (en) Release mechanism
AU2794199A (en) Thyroid hormone replacement using sustained release triiodothyronine
AUPP279698A0 (en) Sustained release formulation
AU6220798A (en) Release agent
GB2334486B (en) Release unit
AU1100000A (en) Compliance mechanism
AU6000498A (en) Compounds for use in adept
AU5814498A (en) Novel release latch - c-i-p
AU3543599A (en) Receptors
AUPO956797A0 (en) Quick release device
GB2328549B (en) Brake mechanism for rotator
AU8743898A (en) Pyramidal machine
AU6029298A (en) Bioartificial hormone releasing device
AU4172099A (en) Chelating agents
AU4501799A (en) A new use for glycine
AU3621599A (en) A file system
AU8805298A (en) Quick release compositions
GB9810681D0 (en) Hormone

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase